CLRB Historical PE Ratio image   This CLRB PE ratio history page last updated 7/12/2025
CLRB Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q1 2025
5/13/2025
7.20-0.14-0.56NA
Q4 2024
3/13/2025
9.00-0.01-0.04NA
Q3 2024
11/18/2024
53.10-0.40-1.60NA
Q2 2024
10/29/2024
61.50-0.18-0.72NA
Q1 2024
5/14/2024
95.40-0.74-2.96NA
Q4 2023
3/27/2024
109.20-0.40-1.60NA
Q3 2023
11/13/2023
62.10-0.82-3.28NA
Q2 2023
8/14/2023
48.90-0.73-2.92NA
Q1 2023
5/4/2023
44.40-0.76-3.04NA
Q4 2022
3/9/2023
51.00-0.55-2.20NA
Q3 2022
11/3/2022
57.00-1.28-5.12NA
Q2 2022
8/5/2022
155.40-1.22-4.88NA
Q1 2022
5/10/2022
120.00-1.00-4.00NA
Q4 2021
3/21/2022
189.00-0.90-3.60NA
Q3 2021
11/8/2021
282.00-1.00-4.00NA
Q2 2021
8/9/2021
303.00-1.10-4.40NA
Q1 2021
5/10/2021
396.00-1.30-5.20NA
Q4 2020
3/2/2021
603.00-0.60-2.40NA
Q3 2020
11/9/2020
348.00-1.50-6.00NA
Q2 2020
8/10/2020
423.00-2.60-10.40NA
Q1 2020
5/7/2020
489.00-4.20-16.80NA
Q4 2019
3/9/2020
594.00-3.30-13.20NA
Q3 2019
11/12/2019
324.00-4.20-16.80NA
Q2 2019
8/12/2019
657.00-4.60-18.40NA
Q1 2019
5/6/2019
723.00-7.60-30.40NA
Q4 2018
2/26/2019
591.000.602.40246.2
Q3 2018
11/13/2018
732.00-16.50-66.00NA
Q2 2018
8/10/2018
855.00-16.90-67.60NA
Q1 2018
5/11/2018
3330.00-21.00-84.00NA
Q4 2017
3/21/2018
3540.00-34.00-136.00NA
Q3 2017
11/9/2017
4920.00-16.00-64.00NA
Q2 2017
8/14/2017
4410.00-23.00-92.00NA
Q1 2017
5/11/2017
5610.00-24.00-96.00NA
Q4 2016
3/15/2017
7710.00-34.00-136.00NA
Q3 2016
11/10/2016
5310.00-43.00-172.00NA
Q2 2016
8/11/2016
8040.00-49.00-196.00NA
Q1 2016
5/12/2016
4440.0091.00364.0012.2
Q4 2015
3/10/2016
14850.00-618.00-2472.00NA
Q3 2015
11/12/2015
47400.00-250.00-1000.00NA
Q2 2015
8/12/2015
91500.00-300.00-1200.00NA
Q1 2015
5/21/2015
81300.00-300.00-1200.00NA
Q4 2014
3/24/2015
82200.00-560.00-2240.00NA
Q3 2014
11/11/2014
79200.00-100.00-400.00NA
Q2 2014
8/20/2014
92700.00-730.00-2920.00NA
Q1 2014
5/14/2014
9900.00-1000.00-4000.00NA
CLRB PE History Chart
PeriodPriceGAAPTTMPE
Q1 2025
5/13/2025
7.20-0.14-0.73NA
Q4 2024
3/13/2025
9.00-0.01-0.59NA
Q3 2024
11/18/2024
53.10-0.40-1.32NA
Q2 2024
10/29/2024
61.50-0.18-1.32NA
Q1 2024
5/14/2024
95.40-0.74-2.69NA
Q4 2023
3/27/2024
109.20-0.40-2.71NA
Q3 2023
11/13/2023
62.10-0.82-2.86NA
Q2 2023
8/14/2023
48.90-0.73-3.32NA
Q1 2023
5/4/2023
44.40-0.76-3.81NA
Q4 2022
3/9/2023
51.00-0.55-4.05NA
Q3 2022
11/3/2022
57.00-1.28-4.40NA
Q2 2022
8/5/2022
155.40-1.22-4.12NA
Q1 2022
5/10/2022
120.00-1.00-4.00NA
Q4 2021
3/21/2022
189.00-0.90-4.30NA
Q3 2021
11/8/2021
282.00-1.00-4.00NA
Q2 2021
8/9/2021
303.00-1.10-4.50NA
Q1 2021
5/10/2021
396.00-1.30-6.00NA
Q4 2020
3/2/2021
603.00-0.60-8.90NA
Q3 2020
11/9/2020
348.00-1.50-11.60NA
Q2 2020
8/10/2020
423.00-2.60-14.30NA
Q1 2020
5/7/2020
489.00-4.20-16.30NA
Q4 2019
3/9/2020
594.00-3.30-19.70NA
Q3 2019
11/12/2019
324.00-4.20-15.80NA
Q2 2019
8/12/2019
657.00-4.60-28.10NA
Q1 2019
5/6/2019
723.00-7.60-40.40NA
Q4 2018
2/26/2019
591.000.60-53.80NA
Q3 2018
11/13/2018
732.00-16.50-88.40NA
Q2 2018
8/10/2018
855.00-16.90-87.90NA
Q1 2018
5/11/2018
3330.00-21.00-94.00NA
Q4 2017
3/21/2018
3540.00-34.00-97.00NA
Q3 2017
11/9/2017
4920.00-16.00-97.00NA
Q2 2017
8/14/2017
4410.00-23.00-124.00NA
Q1 2017
5/11/2017
5610.00-24.00-150.00NA
Q4 2016
3/15/2017
7710.00-34.00-35.00NA
Q3 2016
11/10/2016
5310.00-43.00-619.00NA
Q2 2016
8/11/2016
8040.00-49.00-826.00NA
Q1 2016
5/12/2016
4440.0091.00-1077.00NA
Q4 2015
3/10/2016
14850.00-618.00-1468.00NA
Q3 2015
11/12/2015
47400.00-250.00-1410.00NA
Q2 2015
8/12/2015
91500.00-300.00-1260.00NA
Q1 2015
5/21/2015
81300.00-300.00-1690.00NA
Q4 2014
3/24/2015
82200.00-560.00-2390.00NA
Q3 2014
11/11/2014
79200.00-100.00NANA
Q2 2014
8/20/2014
92700.00-730.00NANA
Q1 2014
5/14/2014
9900.00-1000.00NANA
Quotes delayed 20 minutes

Email EnvelopeFree CLRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CLSD PE Ratio History
CLSN PE Ratio History
CLVS PE Ratio History
CLXT PE Ratio History
CLYM PE Ratio History
CMAX PE Ratio History
CMD PE Ratio History
CMPI PE Ratio History
CMPX PE Ratio History
CMRX PE Ratio History
How should the CLRB historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cellectar Biosciences. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CLRB Historical PE Ratio page.

What is the average historical PE for CLRB based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CLRB historical PE ratio using the annualized quarterly earnings method works out to 129.2.

What is the average historical PE for CLRB based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CLRB historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CLRB Historical PE Ratio information for Cellectar Biosciences' stock. The average CLRB historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 129.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CLRB historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CLRB historical PE result, against the recent PE: when this page was posted on 7/11/2025, the most recent closing price for CLRB had been 4.88, and the most recent quarterly earnings result, annualized, was 2.4. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CLRB PE on 7/11/2025 based on annualized quarterly EPS was 2.0. Based on CLRB's history, that recent PE is low relative to the historical average, with the recent PE 98.5% lower than the historical average PE across our data set for Cellectar Biosciences.

For self directed investors doing their due diligence on CLRB or any other given stock, valuation analysis for CLRB can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cellectar Biosciences PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CLRB. Thanks for visiting, and the next time you need to research CLRB Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of DXB, CVB Split History, Institutional Holders of FSII.

 

CLRB Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2025, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.